Search Results - "Cramer, C.K."

Decreased Radiation Utilization During the Economic Crisis of 2008-2009 by Cramer, C.K, Chino, J

Get full text

Ipsilateral Tonsil Chemoradiation: Improved Toxicity Compared to Bilateral Radiation and Effective Rates of Local-Regional Control by Cramer, C.K, Palta, M, Patel, P, Brizel, D.M

Get full text

Ipsilateral versus Bilateral Neck Radiation Therapy for Tonsillar Squamous Cell Carcinoma by Natesan, D., Cramer, C.K., Oyekunle, T., Niedzwiecki, D., Brizel, D.M., Mowery, Y.M.

Get full text

Genomic Signature for Initial Brain Metastasis Velocity (iBMV) in Non-Small Cell Lung Cancer Patients: The Elusive Biomarker to Predict the Development of Brain Metastases? by Glynn, S.E., Lanier, C.M., Choi, A.R., D'Agostino, R., Farris, M., Abdulhaleem, M., Wang, Y., Smith, M., Ruiz, J., Lycan, T., Petty, W., Cramer, C.K., Tatter, S.B., Laxton, A., White, J., Su, J., Whitlow, C.T., Xing, F., Chan, M.D., Helis, C.A.

“…No prior studies have attempted to identify a biomarker for initial brain metastasis velocity (iBMV), with limited studies attempting to correlate genomic data…”
Get full text

External Validation of Oligometastatic Genomic Signature in Non-Small Cell Lung Cancer Patients by Choi, A.R., Lanier, C.M., Glynn, S.E., D’Agostino, R., Farris, M., Abdulhaleem, M., Wang, Y., Smith, M., Ruiz, J., Lycan, T., Petty, W., Cramer, C.K., Tatter, S.B., Laxton, A., White, J., Li, W., Su, J., Whitlow, C.T., Xing, F., Chan, M.D.

“…We recently presented a genomic signature that was predictive of both oligometastatic disease state and oligometastatic progression in patients with brain…”
Get full text

Genomic Signature for Leptomeningeal Progression in Brain Metastasis Patients Using Liquid Biopsy-Acquired Comprehensive Genomic Profiling by Lanier, C.M., Choi, A.R., D'Agostino, R., Glynn, S.E., Abdulhaleem, M., Smith, M., Wang, Y., Ruiz, J., Lycan, T., Petty, W.J., Cramer, C.K., Tatter, S.B., Laxton, A., White, J., Whitlow, C.T., Xing, F., Chan, M.D.

“…Biomarkers for leptomeningeal disease (LD) are not well elucidated in the literature. Few studies have shown a correlation between genomic data and LD…”
Get full text

5 Year Survivors from Brain Metastases Treated with Stereotactic Radiosurgery: Biology, Improving Treatments or Just Plain Luck? by Pearce, J.B., Hsu, F.C., Lanier, C.M., Cramer, C.K., Ruiz, J., Lo, H.W., Xing, F., Li, W., Whitlow, C.T., White, J., Tatter, S.B., Laxton, A., Chan, M.D.

Get full text

Long-Term Survivors of Stereotactic Radiosurgery for Brain Metastases: Do Distant Brain Failures Reach a Plateau and what Factors are Associated with a Brain Metastasis Velocity of Zero? by Lanier, C.M., Pearce, J.B., Isom, S., Xing, F., Lo, H.W., Whitlow, C.T., Ruiz, J., White, J., Laxton, A., Tatter, S.B., Cramer, C.K., Chan, M.D.

Get full text

Results of a Third or Fourth Radiosurgery for Trigeminal Neuralgia by Helis, C.A., Hughes, R.T., Cramer, C.K., Munley, M.T., Bourland, J.D., Laxton, A., Tatter, S.B., Chan, M.D.

Get full text

Genomic Signature for Oligometastatic Disease in Non-Small Cell Lung Cancer Patients with Brain Metastases by Choi, A.R., D'Agostino, R., Farris, M., Abdulhaleem, M., Wang, Y., Smith, M., Ruiz, J., Lycan, T., Petty, W., Cramer, C.K., Tatter, S.B., Laxton, A., White, J., Su, J., Whitlow, C.T., Xing, F., Chan, M.D.

“…Biomarkers for oligometastatic disease remain elusive and few studies have attempted to correlate genomic data to the presence of true oligometastatic disease…”
Get full text

Gamma Knife Radiosurgery for Bilateral Trigeminal Neuralgia by Helis, C.A., McTyre, E., Munley, M.T., Bourland, J.D., Cramer, C.K., Laxton, A., Tatter, S.B., Chan, M.D.

Get full text

Clinical Outcomes in High Risk WHO Grade II Glioma Patients Treated with Upfront TMZ-Based Chemoradiotherapy by Zarabi, H., Wicks, R., Strowd, R., Russell, G., Banderage, D., Mott, R.T., Laxton, A., Tatter, S.B., White, J., Lo, H.W., Whitlow, C., Debinski, W., Chan, M.D., Lesser, G.J., Cramer, C.K.

Get full text

Cumulative Integral Dose And Repeat Stereotactic Radiosurgery For Trigeminal Neuralgia by Steber, C., Hughes, R.T., Helis, C.A., Cramer, C.K., Bourland, J.D., Munley, M.T., Dezarn, W.A., Hinson, W., Tatter, S.B., Laxton, A., Chan, M.D.

Get full text

Does Integral Dose Relate to Pain Response and Toxicity in Multiple Sclerosis-Related Trigeminal Neuralgia? by Nieto, K., Helis, C.A., Hughes, R.T., Steber, C., Cramer, C.K., Bourland, J.D., Munley, M.T., Dezarn, W.A., Hinson, W., Tatter, S.B., Laxton, A., Chan, M.D.

Get full text

Treatment of Radiation-Induced Meningiomas With Non-Invasive Stereotactic Radiosurgery by Razavian, N., Helis, C.A., Laxton, A., Tatter, S.B., Bourland, J.D., Mott, R.T., Lesser, G.J., Strowd, R., Chan, M.D., Cramer, C.K.

“…Radiation-Induced Meningiomas (RIMs) are one of the most common secondary malignancies from prior brain irradiation and are known to be recurrent. While Gamma…”
Get full text

Stereotactic Radiosurgery for Multiple Sclerosis Associated Trigeminal Neuralgia by Helis, C.A., McTyre, E., Munley, M.T., Bourland, J.D., Cramer, C.K., Laxton, A., Tatter, S.B., Chan, M.D.

Get full text

Impact of Salvage Modality on Neurologic Death for Distant Brain Failure after Initial Stereotactic Radiosurgery by LeCompte, M.C., Hughes, R.T., Farris, M., Lanier, C.M., Masters, A.H., Soike, M., Cramer, C.K., Watabe, K., Su, J., Ruiz, J., Laxton, A., Tatter, S.B., Chan, M.D.

Get full text

Limited-Stage Small Cell Lung Cancer: Is Prophylactic Cranial Irradiation Necessary? by Wheless, W.H., Hughes, R.T., Soike, M., Farris, M., Masters, A.H., Helis, C.A., Cramer, C.K., Ruiz, J., Lycan, T., Petty, W.J., Ahmed, T., Chan, M.D., Blackstock, A.W.

Get full text

IMRT With Planned Gamma Knife Radiosurgery Boost for Head and Neck Cancer With Extensive Disease in Proximity to Critical Structures by Farris, J.C., Steber, C., Chan, M.D., Cramer, C.K., Ververs, J.D., Black, P.J., Frizzell, B.A., Laxton, A., Tatter, S.B., Waltonen, J., Patwa, H.S., Sullivan, C.A., Browne, J.D., Greven, K.M., Hughes, R.T.

“…To describe outcomes of a novel paradigm of intensity-modulated radiotherapy (IMRT) in combination with planned Gamma Knife Radiosurgery (GKRS) boost for…”
Get full text

Upfront Immunotherapy at the Time of Metastatic Cancer Diagnosis Leads to Lower Brain Metastasis Velocity in Patient Undergoing Stereotactic Radiosurgery for Brain Metastases by Scott, E., Chan, M.D., Johnston, H., Lanier, C.M., LeCompte, M.C., Cramer, C.K., Ruiz, J., Lo, H.W., Watabe, K., O'Neill, S.S., Whitlow, C.T., Laxton, A., Su, J.

“…Prior series assessing the effect of immunotherapy (I/O) on outcomes of patients receiving stereotactic radiosurgery (SRS) for brain metastases have been…”
Get full text